tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EC Healthcare Schedules Board Meeting to Review Interim Results

Story Highlights
  • EC Healthcare’s board will meet to approve interim results for six months ending September 2025.
  • The meeting will also consider the payment of an interim dividend, impacting stakeholder returns.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EC Healthcare Schedules Board Meeting to Review Interim Results

Meet Your ETF AI Analyst

EC Healthcare ( (HK:2138) ) has issued an update.

EC Healthcare has announced that its board of directors will meet on 28 November 2025 to consider and approve the interim results for the six months ending 30 September 2025. The board will also discuss the potential payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial health and potential returns for stakeholders.

The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.

More about EC Healthcare

EC Healthcare is a company incorporated in the Cayman Islands, operating in the healthcare industry. It is listed on the Hong Kong Stock Exchange and provides a range of healthcare services.

Average Trading Volume: 1,445,399

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$770.4M

For detailed information about 2138 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1